Pancreatic Cancer Research

ResearcherJohns Hopkins UniversityActive in the last 2 years

Fabian Mc. Johnston

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-2794-7179; OpenAlex author ID A5086190978. Sources: OpenAlex.

Their work

Papers
14 (first author 2, last author 2)
Trials
0
Grants
0
Labs led
0
Collaborators
29
Papers, trials and grants by year

2014: 2 papers · 2015: 3 papers · 2016: 1 paper · 2017: 1 paper · 2018: none · 2019: none · 2020: none · 2021: none · 2022: 4 papers · 2023: 2 papers · 2024: 1 paper

Papers 14

  1. Sociodemographic variation in the utilization of minimally invasive surgical approaches for pancreatic cancer. Co-author DOI 10.1016/j.hpb.2024.07.403↗
  2. Palliative Therapies in Metastatic Pancreatic Cancer: Does Medicaid Expansion Make a Difference? Co-author DOI 10.1245/s10434-022-12563-4↗
  3. ASO Author Reflections: Disparities in Receipt of Palliative Therapies for Pancreatic Cancer: Did Medicaid Expansion Help? Co-author DOI 10.1245/s10434-022-12638-2↗
  4. Fragmentation of Care in Pancreatic Cancer: Effects on Receipt of Care and Survival. Co-author DOI 10.1007/s11605-022-05478-8↗
  5. Association of Medicaid Expansion with Pancreatic Cancer Treatment and Outcomes: Evidence from the National Cancer Database. Co-author DOI 10.1245/s10434-021-10709-4↗
  6. ASO Author Reflections: The Challenge of Achieving High-Quality, Equitable Care for Pancreatic Cancer: Might Medicaid Expansion Be a Piece of the Puzzle? First author DOI 10.1245/s10434-021-10713-8↗
  7. Disparities in Access to Oncologic Care in Pancreatic Cancer: A Systematic Review. Last author DOI 10.1245/s10434-021-11258-6↗
  8. Hospital Volume and the Costs Associated with Surgery for Pancreatic Cancer. First author DOI 10.1007/s11605-017-3479-x↗
  9. Survival of patients with resectable pancreatic cancer who received neoadjuvant therapy. Co-author DOI 10.1016/j.surg.2015.09.018↗
  10. Use of neoadjuvant therapy in patients 75 years of age and older with pancreatic cancer. Co-author DOI 10.1016/j.surg.2015.06.017↗
  11. Pre-treatment carbohydrate antigen 19-9 does not predict the response to neoadjuvant therapy in patients with localized pancreatic cancer. Co-author DOI 10.1111/hpb.12448↗
  12. Neoadjuvant therapy for localized pancreatic cancer: guiding principles. Co-author DOI 10.3978/j.issn.2078-6891.2015.053↗
  13. Patency rates of portal vein/superior mesenteric vein reconstruction after pancreatectomy for pancreatic cancer. Co-author DOI 10.1007/s11605-014-2635-9↗
  14. The association between smokeless tobacco use and pancreatic adenocarcinoma: a systematic review. Last author DOI 10.1016/j.canep.2014.08.010↗

Closest collaborators

The 25 strongest of 29 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Annabelle L. Fonseca · 6 shared papers, 2022–2023 · strength 1.22
  2. Martin J. Heslin · 5 shared papers, 2022–2023 · strength 0.96
  3. Hamza Khan · 4 shared papers, 2022–2023 · strength 0.79
  4. Hop S. Tran Cao · 2 shared papers, 2022 · strength 0.43
  5. Paul S. Ritch · 5 shared papers, 2014–2016 · strength 0.24
  6. Bradley A. Erickson · 5 shared papers, 2014–2016 · strength 0.24
  7. Ben George · 5 shared papers, 2014–2016 · strength 0.24
  8. Douglas B. Evans · 5 shared papers, 2014–2016 · strength 0.24
  9. Susan Tsai · 5 shared papers, 2014–2016 · strength 0.24
  10. Kathleen K. Christians · 5 shared papers, 2014–2016 · strength 0.24
  11. Christopher R. Shubert · 1 shared paper, 2024 · strength 0.23
  12. William R. Burns · 1 shared paper, 2024 · strength 0.23
  13. Richard Zheng · 1 shared paper, 2024 · strength 0.23
  14. Kelly J. Lafaro · 1 shared paper, 2024 · strength 0.23
  15. Richard Andrew Burkhart · 1 shared paper, 2024 · strength 0.23
  16. Andy Tran · 1 shared paper, 2024 · strength 0.23
  17. Manish Tripathi · 1 shared paper, 2023 · strength 0.18
  18. Ching-Wei David Tzeng · 1 shared paper, 2022 · strength 0.16
  19. Ashley N. Krepline · 3 shared papers, 2014–2015 · strength 0.14
  20. Parag P. Tolat · 2 shared papers, 2015–2016 · strength 0.11
  21. Marcelo Cerullo · 1 shared paper, 2017 · strength 0.08
  22. Faiz Gani · 1 shared paper, 2017 · strength 0.08
  23. Timothy Michael Pawlik · 1 shared paper, 2017 · strength 0.08
  24. Mary E. Dillhoff · 1 shared paper, 2017 · strength 0.08
  25. Matthew D. Burkey · 1 shared paper, 2014 · strength 0.05

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.